Trainings and Resources
13 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 7/10/2020 (updated 7/20/2022)
Communities of color have experienced significant disparities in health outcomes from COVID-19, as well as barriers to accessing testing. Predominantly white communities have had access to more testing sites than communities that are predominantly made up of Black and Latinx residents.
Posted 6/17/2021 (updated 7/19/2022)
The Centers for Medicare & Medicaid Services (CMS) announced an additional payment amount for administering in-home COVID-19 vaccinations to Medicare beneficiaries who have difficulty leaving their homes or are otherwise hard-to-reach. The U.S. Department of Health & Human Services estimates approximately 1.6 million adults aged 65 or older who may have trouble accessing vaccinations because they have difficulty leaving home.
Posted 4/28/2021 (updated 7/19/2022)
The Administration for Community Living (ACL) offers examples and promising practices for states, municipalities, community-based partners and anyone else working to ensure access to vaccination. Earlier this month, the U.S. Department of Health & Human Services released an issue brief on potential barriers to vaccination for homebound older adults.
The Centers for Disease Control & Prevention (CDC) recommended a booster shot of the Pfizer-BioNTech COVID-19 vaccine for children ages 5-11 who completed their primary vaccination more than five months ago. The booster shot is 10 micrograms, the same dosage as the primary series for this age group. The CDC also strengthened its recommendation that those 12 and older who are immunocompromised and those 50 and older should receive a second booster dose at least four months after their first. Visit COVID.gov to find nearby locations for masks, testing, vaccines, and treatment.
Posted 5/24/2022 (updated 5/23/2022)
Before the COVID-19 pandemic began, hospital closures were increasing in rural communities across the nation: 116 rural hospitals closed between 2010 and 2019. Over the past two years, federal relief has helped stabilize facilities, and the pace of closures slowed. However, this assistance was temporary, and rural hospitals continue to struggle financially and to recruit and retain nurses and other health care employees.
The Department of Health and Human Services (HHS) is announcing a funding opportunity of nearly $15 million for a three-year federal grant to establish a Substance Abuse and Mental Health Services Administration (SAMHSA) program that will strengthen the delivery of behavioral health care to residents of nursing homes and other long-term care facilities. Funded by the Centers for Medicare & Medicaid Services (CMS), this program will establish a Center of Excellence for Building Capacity in Nursing Facilities to Care for Residents with Behavioral Health Conditions (Center for Excellence). This builds on President Biden’s State of the Union emphasis on the critical importance of ensuring residents of nursing homes and other long-term care facilities receive high-quality care.
Nearly 92,000 Americans died of drug overdoses in 2020, marking a 30% increase from the year before, a 75% increase over five years and by far the highest annual total on record, according to the Centers for Disease Control and Prevention (CDC). Preliminary figures suggest that the 2021 death toll from overdoses may be even higher. While overdose death rates have increased in every major demographic group in recent years, no group has seen a bigger increase than Black men. As a result, Black men have overtaken White men and are now on par with American Indian or Alaska Native men as the demographic groups most likely to die from overdoses.
Posted 1/27/2021 (updated 9/2/2021)
On December 11, 2020, the U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older. The emergency use authorization allows the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the U.S.
Posted 8/11/2020 (updated 9/2/2021)
Through the Quality Improvement Organization (QIO) Program, the Centers for Medicare & Medicaid Services (CMS) hosts a weekly webinar series (every Thursday, 4-5 pm ET) to provide training for infection control processes in nursing homes.
Posted 5/22/2020 (updated 9/2/2021)
Benzodiazepines, which are associated with safety-related harms for older adults, were not covered when the US Medicare Part D prescription drug benefit began. Coverage wasextended to benzodiazepines in 2013.